The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of HMPL-453, a selective FGFR tyrosine kinase inhibitor (TKI), in patients with previously treated advanced cholangiocarcinoma containing FGFR2 fusions.
 
Jianming Xu
No Relationships to Disclose
 
Jianping Xiong
No Relationships to Disclose
 
Shanzhi Gu
No Relationships to Disclose
 
Zuoxing Niu
No Relationships to Disclose
 
Fei Yin
No Relationships to Disclose
 
Beicheng Sun
No Relationships to Disclose
 
Lan Zhang
No Relationships to Disclose
 
Fuxiang Zhou
No Relationships to Disclose
 
Chunyi Hao
No Relationships to Disclose
 
Yueyin Pan
No Relationships to Disclose
 
Wensheng Qiu
No Relationships to Disclose
 
Yi Gao
No Relationships to Disclose
 
Yongxin Ren
Employment - HUTCHMED
 
Songhua Fan
Employment - HUTCHMED
 
Michael Shi
Employment - HUTCHMED
 
Weiguo Su
Employment - HUTCHMED
Leadership - HUTCHMED